S-Adenosyl-L-methionine, identified by the Chemical Abstracts Service Registry Number 29908-03-0, is a naturally occurring molecule that serves as one of the most important and ubiquitous methyl donors in biological systems. Its molecular formula is C₁₅H₂₂N₆O₅S, with a molecular weight of approximately 398.44 grams per mole for the base compound, though it is typically encountered as the stable salt form, such as the tosylate disulfate or butanedisulfonate, due to its inherent chemical instability. The IUPAC name for this compound is (3S)-5'-[(3-amino-3-carboxypropyl)methylsulfonio]-5'-deoxyadenosine, a structure that reflects its unique composition as an adenosyl group linked to a sulfonium center derived from the amino acid methionine and adenosine triphosphate. This sulfonium structure, which carries a positive charge on the sulfur atom, is the critical functional feature that enables its role as the principal biological methyl donor, with the labile methyl group attached to the sulfonium center capable of transfer to a wide array of acceptor molecules including nucleic acids, proteins, phospholipids, and small molecule neurotransmitters.
The biological synthesis of S-adenosyl-L-methionine occurs in virtually every living cell through the action of methionine adenosyltransferase, an enzyme that catalyzes the condensation of the essential amino acid L-methionine with adenosine triphosphate. This reaction consumes a significant proportion of the body's methionine pool and produces the highly reactive sulfonium compound, which is rapidly utilized or stabilized. Once formed, S-adenosyl-L-methionine participates in three major classes of biochemical reactions that are fundamental to cellular homeostasis and function. The first and most extensively characterized is transmethylation, wherein the activated methyl group is transferred to a methyl acceptor via the action of specific methyltransferases, producing S-adenosyl-L-homocysteine as a byproduct. This methylation pathway is essential for the regulation of gene expression through DNA and histone methylation, the synthesis of creatine from guanidinoacetate, the formation of phosphatidylcholine from phosphatidylethanolamine in cell membranes, and the catabolism of catecholamine and indoleamine neurotransmitters such as dopamine, norepinephrine, and serotonin.
Beyond its role in transmethylation, S-adenosyl-L-methionine participates in transsulfuration, a pathway that serves as the primary route for the synthesis of glutathione, the body's most abundant endogenous antioxidant. Under conditions of metabolic demand, S-adenosyl-L-methionine can be converted to S-adenosyl-L-homocysteine and subsequently to homocysteine, which is then irreversibly channeled into the transsulfuration pathway through cystathionine β-synthase to generate cysteine, the rate-limiting precursor for glutathione biosynthesis. This connection between S-adenosyl-L-methionine metabolism and glutathione production establishes a critical link between methylation capacity and antioxidant defense, with important implications for conditions involving oxidative stress and hepatic injury. The third major pathway involves aminopropylation, wherein decarboxylated S-adenosyl-L-methionine serves as the donor of aminopropyl groups for the biosynthesis of the polyamines spermidine and spermine, molecules essential for cell proliferation, differentiation, and the stabilization of nucleic acids and membranes.
The clinical applications of S-adenosyl-L-methionine have been extensively investigated, with the compound being approved as a prescription drug in numerous countries outside the United States and widely available as a dietary supplement. Its most well-established therapeutic indications relate to the treatment of depression, osteoarthritis, and cholestasis of pregnancy and other liver disorders. In the context of mood disorders, S-adenosyl-L-methionine has been studied in numerous clinical trials, with meta-analyses demonstrating superior efficacy compared to placebo and comparable effectiveness to standard antidepressant medications, often with a more favorable tolerability profile. The proposed mechanisms underlying its antidepressant effects are multifactorial and include enhanced monoamine neurotransmitter synthesis through increased methylation of catecholamine precursors, upregulation of membrane fluidity and receptor function, and modulation of neurotrophic factors. In osteoarthritis, S-adenosyl-L-methionine has been shown to reduce pain and improve functional outcomes, with evidence suggesting it may stimulate proteoglycan synthesis by chondrocytes while simultaneously exerting anti-inflammatory effects through inhibition of pro-inflammatory cytokine production.
The pharmacokinetic and safety profile of S-adenosyl-L-methionine is characterized by limited oral bioavailability due to extensive first-pass metabolism in the liver, where the molecule is rapidly taken up and metabolized. Following oral administration of stable salt formulations, plasma concentrations rise modestly, but hepatic levels can increase substantially, supporting its use in conditions involving hepatic dysfunction. The compound is distributed into various tissues and crosses the blood-brain barrier, though to a limited extent. Elimination occurs primarily through metabolic pathways, with the methyl groups being transferred to acceptor molecules and the adenosine moiety being incorporated into purine and pyrimidine nucleotide pools. From a safety perspective, S-adenosyl-L-methionine is generally well tolerated, with the most commonly reported adverse effects being gastrointestinal disturbances such as nausea, abdominal discomfort, and diarrhea. Of particular importance is its potential to elevate plasma homocysteine levels in susceptible individuals, as the transmethylation pathway generates S-adenosyl-L-homocysteine, which is hydrolyzed to homocysteine. This has led to caution regarding its use in individuals with hyperhomocysteinemia or those at risk for cardiovascular disease, though the clinical significance of this effect remains an area of active investigation. Additionally, there is a theoretical concern regarding the induction of manic episodes in patients with bipolar disorder, which has been documented in case reports and warrants careful consideration before initiation in this population.
The analytical characterization and stability of S-adenosyl-L-methionine present significant challenges due to the inherent chemical lability of the sulfonium center. In solution, the compound undergoes non-enzymatic degradation through two primary pathways: isomerization to S-adenosyl-L-homocysteine and racemization to the inactive (R,S)-diastereomer, with the rate of degradation accelerated by elevated temperatures, alkaline pH, and the presence of certain counterions. The development of stable salt formulations, particularly the 1,4-butanedisulfonate and tosylate disulfate salts, has been critical to enabling its practical use as a pharmaceutical agent, as these forms provide enhanced stability under ambient storage conditions. Analytical methods for characterizing S-adenosyl-L-methionine and its degradation products typically employ high-performance liquid chromatography with ultraviolet detection, often coupled with mass spectrometry for confirmatory analysis. The commercial production of S-adenosyl-L-methionine involves either chemical synthesis or fermentation using specially engineered strains of Saccharomyces cerevisiae or Candida utilis, with the latter approach yielding the naturally occurring (S,S)-isomer with high stereochemical purity. The purity and isomer composition of the final product are critical quality attributes, as the (R,S)-diastereomer possesses reduced biological activity and may accumulate during storage or improper handling.
Q1. Can I get a free sample?
We can send you a samll free sample, and you only need to pay for the shipping cost.
Q2. What is the HyperChem payment term?
T/T in advance
LC at sight
DP at sight
Bank transfer
PayPal
Bitcoin...
Q3. What is HyperChem shipment policy?
Our policy is to strive for the quickest shipment time possible.
For ready stock samples, they are usually shipped within 3 working days after payment received.
For non-ready stock, please contact HyperChem sales team to negotiate.
Q4. What is HyperChem shipment term?
By Express
FedEx UPS DHL EMS
Fast: 3-7 days around, high cost, door to door service
By Air
Suitable for more than 50kg
Fast: 3-7 days, hight cost, port to port, professional broker needed
By Sea
Suitable for more than 500kg
Fast: 7-45 days, low cost, port to port, professional broker needed
We will always attempt to utilize the quickest and most affordable way for customers to receive orders. And follow -up with customers via email for all shipment details as well as updated track information until it arrives without damage.
Q5. What HyperChem will provide after shipment?
For sample orders:
After shipment is done, an timely email including:
1. Track details (Fedex /TNT/DHL/EMS Track number)
2. Packaging photo
3. COA, MSDS, etc
4. Dispatch date & Estimated arriving time
5. Shipping invoice
For commercial orders
A full set of shipment documents as well as package photos can be provided in scan-copy and original, to help customers complete the customs clearance process.
Established in 2013, Hyper Chem has exclusive tie-ups with leading manufacturers, supplying raw materials produced in GMP and ISO 9002 certified facilities, and provides high-quality ingredients and raw materials to cater to the requirements of our diverse range of clients.
Among them, our key client industrial sectors around the global are:
Pharmaceuticals
Nutrition Ingredients/ Dietary supplements
Cosmetic Ingredients
Food Ingredients
Veterinary API
Agriculture fertilizer
Custom Synthesis lab supply
HyperChem provides to its wonderful and honorable clients comprehensive purchasing and distribution services which ensure that we are delivering the right generic, raw, or customized product, make sure that we are delivering it at the right time, ensure that it is delivered in the specified amount, and in the right kind of packaging to clients and customers of all types of industries irrespective of their size of operation.
Russia
United States
